Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Agata Wieczorkiewicz-Kabut"'
Autor:
Martyna Wlodarczyk, Agata Wieczorkiewicz-Kabut, Krzysztof Białas, Anna Koclęga, Izabela Noster, Patrycja Zielińska, Grzegorz Helbig
Publikováno v:
Turkish Journal of Hematology, Vol 41, Iss 1, Pp 9-15 (2024)
Objective: Cytomegalovirus (CMV) reactivation is a life-threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT). Introduction of letermovir (LMV) seems to improve posttransplant outcomes, but delayed-onset CMV reactiv
Externí odkaz:
https://doaj.org/article/4372bd87ff6d440687b7a4798f652c40
Autor:
Agnieszka Pluta, Kinga Krawiec, Agata Wieczorkiewicz-Kabut, Grzegorz Helbig, Piotr Strzałka, Magdalena Dutka, Jan Zaucha, Małgorzata Sobczyk-Kruszelnicka, Sebastian Giebel, Tomasz Czerw, Joanna Kujawska, Anna Czyż, Maciej Majcherek, Tomasz Wróbel, Patrycja Mensah-Glanowska, Sylwia Bartyzel-Palińska, Tomasz Sacha, Magdalena Czemerska, Kamila Stańczak, Agnieszka Wierzbowska, Lidia Gil
Publikováno v:
HemaSphere, Vol 7, p e875498b (2023)
Externí odkaz:
https://doaj.org/article/a819bf5431294da0843edaf35d14b222
Autor:
Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Anna Koclęga, Krzysztof Woźniczka, Patryk Węglarz, Kinga Boral, Dariusz Kata, Patrycja Zielińska, Grzegorz Helbig
Publikováno v:
International Journal of Hematology. 116:922-928
Steroid-refractory acute graft-versus-host disease (SR-aGVHD) remains a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Ruxolitinib (RUX), an oral JAK1 and JAK2 inhibitor, has recently been
Autor:
Katarzyna Duda, Agata Wieczorkiewicz-Kabut, Anna Koclęga, Patrycja Zielińska, Krzysztof Woźniczka, Helena Krzemień, Anna Armatys, Grzegorz Helbig
Publikováno v:
Annals of Hematology.
The incidence of AML increases with age. The implementation of reduced intensity conditioning and progress in supportive care enabled to perform allo-HSCT in elderly patients. The main objective of the study was to assess the safety and efficacy of a
Autor:
Patrycja Zielińska, Izabela Noster, Agata Wieczorkiewicz-Kabut, Krzysztof Białas, Anna Koclęga, Grzegorz Helbig
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Patrycja Zielińska, Anna Kopińska, Grzegorz Helbig
Publikováno v:
Polish Archives of Internal Medicine.
Autor:
Adrianna Spałek, Krzysztof Woźniczka, Anna Armatys, Agata Wieczorkiewicz-Kabut, Izabela Noster, Grzegorz Helbig
Publikováno v:
Acta Haematologica Polonica. 53:66-68
Autor:
Anna Kopińska, Patryk Węglarz, Anna Koclęga, Agata Wieczorkiewicz-Kabut, Krzysztof Woźniczka, Anna Armatys, Adrianna Spałek, Iwona Grygoruk-Wiśniowska, Sebastian Grosicki, Aleksandra Butrym, Jarosław Czyż, Agata Obara, Tomasz Gromek, Grzegorz Helbig
Publikováno v:
Clinical lymphoma, myelomaleukemia.
Patients with relapsed/refractory acute myeloid leukemia (r/r AML) are characterized as having a poor prognosis. The only viable option of treatment for these patients is allogenic stem cell transplantation (allo-HSCT). Therefore, we have attempted t
Autor:
Adrianna Spałek, Agata Wieczorkiewicz-Kabut, Krzysztof Woźniczka, Anna Koclęga, Konrad Matlak, Dariusz Kata, Grzegorz Helbig, Anna Armatys
Publikováno v:
Acta Haematologica Polonica. 52:103-109
Introduction: Therapy-related acute myeloid leukemia (t-AML) remains a late consequence of exposure to cytotoxic chemo- and/or radiotherapy for prior malignant or non-malignant disorders. The prognosis of t-AML is extremely poor, and allogeneic stem
Autor:
Agata Wieczorkiewicz-Kabut, Anna Koclęga, Anna Armatys, Marta Panz-Klapuch, Dariusz Kata, Krzysztof Wozniczka, Grzegorz Helbig, Anna Kopińska
Publikováno v:
Neoplasma. 67:1431-1436
High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (ASCT) remains a valuable therapeutic approach for relapsed and refractory (R/R) patients with diffuse large B-cell lymphoma (DLBCL). The aim of the study was to ev